BP-C1 in Short-term Treatment of Patients With Metastatic Breast Cancer

NCT02783794 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Breast Cancer
Stage IV Breast Cancer

Interventions

DRUG: BP-C1
DRUG: Placebo

Sponsor

Meabco A/S

Collaborators

[object Object]
[object Object]